CJC-1295 has several modifications for improved pharmacokinetics, including the substitution of four amino acids in the original 29 amino acid chain, which improves the peptides stability and effectiveness [4, 5, 6]: At the second position, L-alanine is replaced with D-alanine, heightening resistance to the enzyme dipeptidyl peptidase-4 (DPP-4), which plays a crucial role in deactivating many peptide-based medications
Used extensively in laboratory and research settings for reconstitution of peptide compounds
Once mixed, peptides stay stable for twenty-eight days when refrigerated
DSIP works more directly on sleep architecture, enhancing deep sleep phases regardless of baseline anxiety levels
Always consult a qualified healthcare professional before starting or modifying any treatment, including the use of investigational peptides such as AOD-9604
Central nervous system biogenic amine targets for control of appetite and energy expenditure